Differential Risky Behaviors among HIV Positive and HIV Negative People

Journal Title: International Journal of Virology and AIDS - Year 2017, Vol 4, Issue 1

Abstract

In the past years, HIV prevention efforts have increased with focus on people living with HIV and AIDS (PLWHA) in addition to addressing risk reduction efforts targeting HIV-uninfected individuals. HIV prevalence is 6.3% in Yaounde. This prevalence calls for improvement of prevention strategies. In Cameroon, sensitization activities are continuous and preventive strategy is directed towards HIV negative people. We assessed the suitability of positive prevention in Cameroon, through the comparison of risky behaviors between HIV infected and non-infected people. Methods HIV positive and HIV negative people were recruited in the capital city of Cameroon. Data were collected through a structured questionnaire, pretested and validated, before and after the knowledge of HIV status. The information collected include: Age at first sexual intercourse, number of sexual partners, usage of condoms and frequency of sexual intercourses. Results A total of 320 participants were enrolled, among which 162 People living with HIV (of which 67.3% female) and 158 HIV sero-negative/ignorant people (of which 63.92% female). 18.3% of PLWHA reported having sex before the age of 15 against 10.8% of HIV sero-negative/ignorant people (p = 0.001). PLWHA had more sexual partners than HIV sero-negative/ignorant before and after the knowledge of their HIV status (P = 0.000 and p = 0.001 respectively). Among PLWHA, 39.2% never used condoms before starting treatment against 15.3% of HIV negative (p = 0.000). Before being aware of their HIV status, PLWHA used less condoms than HIV sero-negative/ignorant (p = 0.000). After the awareness of their status, there was no significant difference (p = 0.37) in condoms usage in the two groups, implying risk reduction among PLWHA. Conclusions PLWHA present more risky behavior than HIV-negative and HIV ignorant. Thus positive prevention strategies could be developed and implemented in Cameroon. Furthermore, given the improved use of condoms by PLWHA after awareness of their HIV status, we foresee success in positive prevention.

Authors and Affiliations

Keywords

Related Articles

Successful Treatment of Chronic Hepatitis C using Pegylated Interferon and Ribavirin in a Patient with Sheehan's Syndrome

A 50-year-old female with Sheehan's syndrome was treated for chronic hepatitis C using pegylated interferon-α2b and ribavirin. The patient's HCV-RNA status was negative by the fourth week and remained undetectable until...

Nucleoside Reverse Transcriptase Inhibitor (NRTI) Associated Macrocytosis

Macrocytosis has been associated with several disease states, vitamin deficiencies, and medications, with nucleoside reverse transcriptase inhibitors (NRTIs) being a less commonly identified cause. NRTIs are frequently u...

Determinants of Survival in HIV Patients: A Retrospective Study of Dilla University Hospital HIV Cohort

Introduction:Highly Active Antiretroviral Therapy (HAART) has remarkably improved the survival of Human Immunodeficiency Virus (HIV) patients though it is not sufficient alone to achieve better HIV related clinical outco...

Hepatitis B Induced Kaposi Sarcoma Flare

Kaposi Sarcoma (KS) is a malignant disease that originates from the vascular endothelium and has a very variable clinical course. KS is a vascular endothelial malignancy and the neoplastic cells are closely related to ly...

The Monitoring of Lymphocyte Populations may be Optional in Patients with Suppressed Viremia: A Two Years Observational Study

The determination of lymphocyte populations (LPs) traditionally has been included in the routine follow-up of HIV-infected patients as an indicator of the degree of immune suppression and of the need to start treatment,...

Download PDF file
  • EP ID EP354756
  • DOI 10.23937/2469-567X/1510037
  • Views 100
  • Downloads 0

How To Cite

(2017). Differential Risky Behaviors among HIV Positive and HIV Negative People. International Journal of Virology and AIDS, 4(1), 1-7. https://europub.co.uk/articles/-A-354756